Cellectar Biosciences (CLRB) EBT (QoQ) (2010 - 2025)
Cellectar Biosciences (CLRB) EBT (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Cellectar Biosciences | 6.70 Mn | 6.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.76% |
| Sep 30, 2025 | 24.39% |
| Jun 30, 2025 | -0.98% |
| Mar 31, 2025 | 94.55% |
| Dec 31, 2024 | -757.52% |
| Sep 30, 2024 | 2.85% |
| Jun 30, 2024 | -13.05% |
| Mar 31, 2024 | 10.29% |
| Dec 31, 2023 | -47.19% |
| Sep 30, 2023 | -12.83% |
| Jun 30, 2023 | 3.20% |
| Mar 31, 2023 | 88.98% |
| Dec 31, 2022 | -900.51% |
| Sep 30, 2022 | -8.00% |
| Jun 30, 2022 | -21.10% |
| Mar 31, 2022 | 0.24% |
| Dec 31, 2021 | 0.59% |
| Sep 30, 2021 | 3.85% |
| Jun 30, 2021 | 0.66% |
| Mar 31, 2021 | -70.61% |